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A B S T R A C T
Na+/Ca2+ exchanger (NCX) is the main Ca2+ transporter in cardiac myocytes. Its inhibition could be expected
to exert positive inotropic action by accumulation of cytosolic Ca2+ ([Ca2+]i). However, we have observed only
a marginal positive inotropic eﬀect upon selective inhibition of NCX, which was enhanced when forward activity
was facilitated. Here we attempted to clarify the underlying mechanism of the limited inotropic action of se-
lective NCX inhibition by a novel inhibitor ORM-10962 on canine ventricular myocytes. 1 µM ORM-10962
reduced the Ca2+ content of sarcoplasmic reticulum (SR) when the reverse NCX was favoured, while SR Ca2+
content was increased by ORM-10962 under conditions favouring the forward activity, like elevation of [Ca2+]i.
L-type Ca2+ current (ICa) was not aﬀected by 1 µM ORM-10962 in the absence of SR Ca2+ release, while ICa was
suppressed by ORM-10962 during normal Ca2+ cycling. The apparent degree of forward NCX inhibition was
dependent on the elevation of [Ca2+]i, suggesting that an increased driving force of forward NCX can also limit
the accumulation of [Ca2+i ]. We concluded that in healthy myocardium the possible positive inotropic potential
of NCX inhibition is considerably weaker than it was expected earlier by theoretical assumptions. The underlying
mechanism may involve the autoregulation of Ca2+ handling and/or the preserved inducibility of forward NCX
by high [Ca2+]i. This limitation of selective NCX inhibition seen in undiseased myocardium requires further
studies in failing heart, which may allow correct evaluation of the potential therapeutic value of selective NCX
inhibitors in the treatment of heart failure.
1. Introduction
Na+/Ca2+ exchanger (NCX) is believed to be the main transport
mechanism in regulation of cellular Ca2+ homeostasis in cardiac
myocytes. The forward mode operation of NCX is considered as the
main route of Ca2+ removal balancing the Ca2+ inﬂux generated by the
L-type Ca2+ current (ICa) and the reverse mode NCX activity. Reverse
mode NCX itself is considered to play important role in initiation of
Ca2+ release from the SR (Sipido et al., 1997), acting synergistically
with ICa and contributing signiﬁcantly to the actual Ca2+ load of the
cell (Aronsen et al.; al.,; Blaustein and Lederer, 1999). Since [Ca2+]i,
[Na+]i and the membrane potential change dynamically during the
cardiac cycle, regulation of the balance between the reverse and for-
ward mode NCX activity is a result of a ﬁnely tuned interplay between
these parameters (Weber et al., 2002).
Ca2+ extrusion via forward mode NCX is supposed to be dominant
regarding the amount of Ca2+ removed from the cell, however, the shift
in the balance between reverse and forward mode NCX activity can be
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the result of physiological adaptation or pathophysiological alterations
(Baczko et al., 2003;2003, 2004). Reverse-mode NCX is stimulated by
intracellular Na+ load, occurring in ischemia-reperfusion injury or
heart failure (Despa and Bers, 2013). The enhanced activity of reverse
mode NCX appears to play a compensatory mechanism in the blunted
Ca2+ cycling of the failing heart (Baartscheer et al., 2003). On the other
hand, since NCX expression may be enhanced in heart failure, Ca2+
eﬄux via forward mode NCX may contribute to the observed Ca2+ loss
and inotropic abnormality (Ottolia and Philipson, 2013). In addition,
forward mode NCX may also generate arrhythmogenic inward current
upon uncontrolled SR Ca2+ release (Pott et al., 2012). Based on these
observations, a promising therapeutic potential was raised for phar-
macological NCX inhibition (Pott et al., 2011). In heart failure, in-
hibition of Ca2+ eﬄux via forward mode NCX may facilitate Ca2+
uptake into the SR, thereby improving cardiac contractility (Hobai
et al., 2004).
Experimental studies investigating this issue, however, produced
divergent results. For example, in previous studies we found that
SEA0400 produced a positive inotropic eﬀect in rat (Acsai et al., 2007;
Farkas et al., 2008), but not in canine cardiac myocytes (Birinyi et al.,
2008). In contrast, SEA0400 proved to be positively inotropic in
porchine cardiac cells, suggesting a signiﬁcant impact of the experi-
mental conditions and possible interspecies diﬀerences (Ozdemir et al.,
2008). Further diﬃculty may arise from the fact that conventional NCX
blockers seem to exert a moderate but signiﬁcant suppression of ICa
(Birinyi et al., 2005), an eﬀect appeared to be involved in earlier results
obtained with SEA0400 and SN-6 (Bourgonje et al., 2013; Gandhi et al.,
2013). As a consequence, the critical requirement for an NCX inhibitor
is the maximally improved selectivity for NCX.
The novel NCX inhibitor ORM-10962 ([2-(4-hydroxypiperidin-1-yl)-
N-(6-((2-phenylchroman-6-yl)oxy)yridine-3-yl)acetamide]) seems to
meet this requirement. As it was shown in our previous study (Kohajda
et al., 2016) ORM-10962 is a potent and selective NCX inhibitor having
IC50 values in the nanomolar range (67 and 55 nM for the reverse and
forward mode inhibition, respectively) without any eﬀect on other
transmembrane currents. In the present study we attempted to clarify
the underlying mechanism of the inotropic eﬀect of the selective NCX
inhibitor ORM-10962 in canine ventricular cardiomyocytes. This pre-
paration was chosen since the electrical properties of canine ventricular
cells resemble most those of human ones (Szentadrassy et al., 2005).
Our results suggest that the capability of selective NCX inhibition to
cause positive inotropy is considerably limited by the autoregulation of
SR-related Ca2+ handling and/or by the sustained inducibility of NCX
by elevated [Ca2+]i providing an increased driving force for forward
mode operation.
2. Materials and methods
2.1. Animals
Ventricular myocytes were obtained from hearts of adult mongrel
dogs of either sex (8–16 kg), purchased from a recognised supplier.
Dogs were sedated (xylazine, 1 mg/kg, i.v.) and anaesthetised (thio-
pental, 30 mg/kg i.v.) before opening the chest. Hearts were rapidly
removed and rinsed in oxygenated modiﬁed Locke's solution containing
(mM): NaCl 120, KCl 4, CaCl2 1.0, MgCl2 1, NaHCO3 22 and glucose 11,
pH = 7.4 when saturated with 95% O2 and 5% CO2. Left ventricular
myocytes were enzymatically dissociated as described earlier (Jost
et al., 2013).
All experiments were conducted in compliance with the Guide for
the Care and Use of Laboratory Animals (USA NIH publication no 85-
23, revised 1996) and conformed to Directive 2010/63/EU of the
European Parliament. The protocols were approved by the Review
Board of the Department of Animal Health and Food Control of the
Ministry of Agriculture and Rural Development, Hungary (XIII./1211/
2012).
2.2. Solutions
Chemicals were purchased from Sigma-Aldrich (St. Louis, MO,
USA), ORM-10962 was granted by Orion Pharma (Espoo, Finland).
Stock solution with concentration of 10 mM was prepared in DMSO,
from which the compound was diluted to reach the ﬁnal concentration
of 1 µM in the experimental solutions.
For recording membrane currents in patch clamp experiments, a
K+-free modiﬁed Tyrode's solution was used, which contained (in mM):
NaCl 130, CsCl 10, Hepes 11.8, MgCl2 0.5, CaCl2 1.8 and glucose 10; pH
= 7.4. Composition of the pipette solution was (in mM): Cs-aspartate
120, TEACl 10, NaCl 5, Hepes 10, MgCl2 0.5, MgATP 5, pH = 7.2. To
induce reverse mode NCX, external Na+ concentration was decreased
to 70 mM, by replacing 60 mM NaCl with cholin-chloride. Solution
changes were carried out with a custom made fast perfusion system
controlled either manually or by the patch clamp protocols. Alterations
from these solutions are described in the Results section when relevant.
All experiments were performed at 37 °C.
2.3. Experimental protocols
Fluorescence signals were recorded using an inverted ﬂuorescent
microscope (Nikon Diaphot) equipped with Cairn system (Cairn
Research Ltd, UK), and was calibrated to estimate free intracellular
[Ca2+] as described previously (Acsai et al., 2011). Unloaded cell
shortening (CS) was simultaneously recorded during the patch clamp
experiments, the data were stored as PC video ﬁles and analysed oﬀ-line
using a Matlab-based CellContract 1.0 software (Tamás Szépe, Uni-
versity of Szeged).
Membrane currents were recorded by using Axopatch 1D ampliﬁer
((Molecular Devices, Sunnyvale, CA, USA) controlled by WinWCP patch
clamp software (John Dempster, University of Strathclyde). Cells were
stimulated at 1 Hz by applying 0 or + 30 mV voltage pulses through
the patch pipette in order to measure ICa and INCX. To estimate Ca2+
content of the SR, 10 mM caﬀeine was applied at − 80 mV under
steady state conditions before and after equilibration with ORM-10962.
Standard delay of the caﬀeine administration after cessation of the
stimulation protocol was ensured by using a software-controlled fast
solution exchange.
2.4. Data analysis and statistics
Data analysis was carried out using WinWCP, Clampﬁt (Molecular
Devices, Sunnyvale, CA, USA) and MS Excel (Microsoft, Redmond, WA,
USA). Single original recordings are presented as traces of membrane
currents, while 5-15 traces for ﬂuorescence and CS were averaged. Data
are expressed as mean± S.E.M. Student’s t-test for paired data (before
and after application of ORM-10962) was used for statistical analysis.
Diﬀerences were considered signiﬁcant when P was less than 0.05.
3. Results
3.1. Eﬀects of NCX inhibition under normal condition
The possible inotropic eﬀects of selective NCX inhibition were in-
vestigated on Ca2+ transient and CS amplitudes under normal condi-
tion (140 mM [Na+]o). The cells were ﬁeld stimulated at 1 Hz and after
steady-state control recordings, 1 µM ORM-10962 was applied. The
representative superimposed traces (Fig. 1A–B) and average results
(Fig. 1C) obtained from 6 myocytes indicate that the amplitudes of both
[Ca2+]i, transients and unloaded CS were increased signiﬁcantly (by
4.22±1.7% and 17.32±2.84%, respectively, P< 0.05). These results
are in line with previous data from our laboratory (Kohajda et al.,
2016).
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3.2. Eﬀects of NCX inhibition on SR Ca2+ content
Since NCX inhibition may aﬀect the balance between sarcolemmal
Ca2+ inﬂux and eﬄux, a change in SR Ca2+ content may reﬂect the net
eﬀect of NCX inhibition, therefore, we estimated the total SR Ca2+
content under diﬀerent experimental conditions. Ca2+ content of the
SR was estimated by integrating the inward NCX current obtained at a
holding potential of − 80 mV in response to 10 mM caﬀeine (Varro
et al., 1993). Fig. 2A–B shows illustrative examples of the inward NCX
current evoked by caﬀeine-induced Ca2+ release before and after NCX
inhibition, and the concomitant changes in the SR Ca2+ content under
various conditions (Fig. 2C–D). Suppression of the transmembrane Na+
gradient by decreasing [Na+]o to 70 mM resulted in an elevation of the
amount of Ca2+ stored in the SR, which was signiﬁcantly diminished
(from 2.19±0.2 to 1.53±0.17 fmol, n = 7, P<0.05) following ap-
plication of ORM-10962.
Fig. 1. Evaluation of positive inotropy of 1 µM ORM-
10962 on isolated canine ventricular cells under
normal conditions. Panels A and B show super-
imposed representative traces of Ca2+ transients (A)
and CS (B) under control conditions (ﬁlled symbols)
and after exposure to 1 µM ORM-10962 (open sym-
bols). The cells were paced using ﬁeld stimulation at
1 Hz. Average results obtained from 6 myocytes are
presented in panel C. Columns and bars represent
mean± S.E.M. values, asterisks denote signiﬁcant
changes from control.
Fig. 2. Eﬀects of 1 µM ORM-10962 on the Ca2+
content of the SR. Upper row: Superimposed inward
NCX current traces evoked by a 10 mM caﬀeine pulse
at low [Na+]o (A), and in the presence of 200 nM
forskolin (B). SR Ca2+ content was calculated from
the integral of INCX. The corresponding individual
and average data, obtained in the absence and pre-
sence of ORM-10962 (ﬁlled and open symbols, re-
spectively) are presented in the bottom row (C, D).
Symbols and bars represent mean± S.E.M. values,
asterisks denote signiﬁcant changes induced by
ORM-10962 in 7 and 10 preparations, respectively.
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Fig. 3. Eﬀects of 1 µM ORM-10962 on out-
ward NCX current (A, C) and CS (B, D) in
the presence of low (70 mM) [Na+]o. Cells
were stimulated at 1 Hz under voltage
clamp conditions using voltage steps to +
30 mV for 100 ms arising from the holding
potential of − 70 mV. Superimposed re-
cordings of membrane currents (A) and CS
(B), obtained in the presence and absence of
ORM-10962. The corresponding individual
and average values are presented in panels C
and D. Membrane current was measured at
the end of the depolarizing pulse. Open
symbols represent results obtained in the
presence of ORM-10962, closed symbols are
the corresponding controls. Symbols and
bars are mean± S.E.M. values, asterisks
denote signiﬁcant changes induced by ex-
posure to ORM-10962 in 8 and 7 myocytes,
respectively.
Fig. 4. Eﬀects of 1 µM ORM-10962 on peak L-type Ca2+ current (A, C), inward NCX tail current (A, D) and CS (B, E) in the presence of 200 nM forskolin. In these experiments the cells
were paced at 1 Hz using voltage steps to 0 mV (lasting for 100 ms and each preceded by a prepulse to − 40 mV) arising from the holding potential of − 70 mV. A, B: Superimposed
records of the membrane currents (A) and CS (B) obtained in the presence and absence of ORM-10962. Individual and average results are presented in panels C-E. Open symbols represent
results obtained in the presence of ORM-10962, closed symbols are the corresponding controls. Symbols and bars are mean±S.E.M. values, asterisks denote signiﬁcant changes induced
by the superfusion with ORM-10962 in 10 cells.
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In contrast, when the forward mode NCX activity was favoured by
increasing [Ca2+]i (using 200 nM extracellular forskolin combined with
low Na+ concentration in the pipette and low voltage stimulation
pulses), inhibition of NCX by 1 µM ORM-10962 signiﬁcantly increased
the Ca2+ content of the SR (from 0.72±0.12 to 0.95±0.14 fmol, n =
10, P<0.05). Accordingly, the reduction or enhancement of CS cor-
related well with the Ca2+ content of the SR, suggesting that SR Ca2+
content may be a key parameter in determining the inotropic eﬀect of
NCX inhibition.
3.3. ORM-10962 inhibits the reverse NCX mediated positive inotropy
To get insight into the underlying mechanisms, transmembrane
currents were recorded using the whole cell patch clamp technique with
simultaneous recording of CS. In the ﬁrst approach the cells were sti-
mulated at 1 Hz with pulses clamped to + 30 mV from the holding
potential of–70 mV. To facilitate Ca2+ inﬂux via reverse mode NCX
activity, positive clamp potential was used and the Na+ content of the
external solution was reduced to 70 mM. Representative traces of
membrane currents recorded under these conditions are shown in
Fig. 3A. Application of ORM-10962 signiﬁcantly decreased the outward
current measured at the end of the + 30 mV pulse (from 150±29 to
82±18 pA, P<0.05, n = 8), indicating an inhibition of the outward
NCX current generated by the reverse mode NCX (Fig. 3C). This marked
reduction in outward NCX current was accompanied by a signiﬁcant
decrease in CS (from 7.7± 1.3 to 4.9±1.2%, P< 0.05, n = 7), in-
dicating the elimination of positive inotropy mediated by the previously
activated reverse mode NCX (Fig. 3B, D).
3.4. Primary inhibition of forward mode NCX and secondary decrease of L-
type calcium current in response to ORM-10962 results in a net positive
inotropic response
In the next series of experiments the NCX balance was shifted
towards forward mode activity. ICa was recorded at 0 mV, which was
preceded by a prepulse to− 40 mV to inactivate fast Na+ current. This,
together with elevation of [Ca2+]i by application of 200 nM forskolin,
was applied to reduce reverse and enhance forward mode NCX activity.
Fig. 4A shows superimposed representative traces of ICa and NCX tail
currents recorded before and after application of 1 µM ORM-10962
under these conditions. The most obvious change induced by ORM-
10962 was the marked reduction of ICa (from − 948±124 to −
613± 91 pA, P<0.05, n = 10, Fig. 4. C), while the concomitant re-
duction of inward NCX tail current is a good indicator of forward mode
NCX inhibition (Fig. 4D). Importantly - in contrast to other studies
using non selective NCX inhibitors - we did not observe any con-
comitant negative inotropic eﬀect after NCX inhibition. In fact, the
reduced ICa was accompanied by a strong increase in CS (from 4.7± 1.2
to 7.6± 1.4%, P<0.05, n = 10) as presented in Fig. 4. B, E. This
suggests that the observed decay in peak ICa is not a direct inhibition,
but may rather be a consequence of the stronger SR Ca2+ release reg-
ulating ICa kinetics through its Ca2+-dependent inactivation mechanism
(Dibb et al., 2007).
3.5. Suppression of the L-type calcium current is dependent on the
magnitude of SR Ca release
Theoretically, the observed decrease in ICa can either be due to
Ca2+-dependent inactivation in response to the elevated Ca2+ release,
but alternatively, can also be a consequence of direct inhibitory action
of ORM-10962 on the Ca2+ channel. Therefore, we investigated the
eﬀect of ORM-10962 on ICa independently from the SR Ca2+ release.
This was achieved by superfusion of caﬀeine to empty the SR ﬁrst time
before, and second time after the exposure to 1 µM ORM-10962, ap-
plying the same pattern of repetitive stimulation to record ICa im-
mediately after the cessation of caﬀeine. Under these conditions the
ﬁrst ICa trace recorded after caﬀeine was not inﬂuenced by SR Ca2+
release, since SR was still empty. Accordingly, no diﬀerence was
Fig. 5. Eﬀects of 1 µM ORM-10962 on peak ICa.
Repetitive stimulation was applied under voltage
clamp conditions after depletion of Ca2+ content of
the SR using a caﬀeine pulse. A, B: Superimposed ICa
records obtained at the beginning (1st pulse,
squares) and the end (steady state, circles) of a re-
petitive stimulation train initiated immediately after
the complete depletion of SR. Average results are
presented in panel C, where symbols and bars in-
dicate mean± S.E.M. values obtained in 5 myocytes.
D: Superimposed representative ICa records obtained
using 10 mM BAPTA-containing pipette solution be-
fore and after exposure to 1 µM ORM-10962. Note
the identical time course of the ICa traces when
[Ca2+]i was eﬀectively buﬀered by BAPTA. Open
and closed symbols represent results obtained in the
presence and absence of ORM-10962, respectively.
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observed in the amplitudes of the ﬁrst post-caﬀeine ICa traces recorded
in the presence and absence of ORM-10962 (Fig. 5A, B). Under steady-
state conditions - as the SR was gradually reﬁlled - ICa amplitude pro-
gressively decreased, but this reduction was signiﬁcantly greater in the
presence than in the absence of ORM-10962 (Fig. 5C). In brief, no
diﬀerence was caused by ORM-10962 in the amplitudes of the ﬁrst post-
caﬀeine traces (in absence of SR Ca2+ release), in sharp contrast to the
marked diﬀerence in ICa amplitude observed under steady-state condi-
tions (suppressed by SR Ca2+ release). This is a robust evidence sup-
porting that ORM-10962 has no direct eﬀect on ICa.
Finally, in separate experiments, the eﬀect of ORM-10962 was
studied using pipette solution containing 10 mM BAPTA, the well-
known Ca2+ chelator having rapid binding kinetics. This was done to
prevent any shift in [Ca2+]i in the vicinity of Ca2+ channels. A re-
presentative pair of ICa traces, obtained in the presence of internal
BAPTA before and after exposure to 1 µM ORM-10962 is displayed in
Fig. 5D. Similar results were obtained in further two experiments. It is
clearly shown that both the amplitudes and the decay kinetics of the
two records are identical, indicating again that ORM-10962 at this
concentration exerted no direct inhibitory action on ICa.
3.6. The elevated driving force of Ca2+ eﬄux can partially compensate for
the reduction Ca2+ extrusion due to forward mode NCX inhibition
The positive inotropic eﬀect of the forward mode NCX inhibition
involves that [Ca2+]i is elevated, which in turn presents an elevated
driving force for the remaining (not inhibited) NCX capacity. It is clear
from our previous experiments (Kohajda et al., 2016) that the forward
mode NCX blockade induced by 1 µM ORM-10962 is not complete,
allows thus to estimate the SR Ca2+ content (Fig. 2). Thus, it appears
that after ORM-10962 the Ca2+-sensitivity of NCX decreases, although
fails to disappear completely. In this case the increased driving force
may partially balance the reduced NCX capacity, which may be mani-
fested as a reduction of the apparent inhibition of inward NCX current,
with a possible consequence of limited Ca2+ accumulation. This point
was studied further utilizing the fact that there are two ways to measure
the inward NCX current that corresponds to the forward mode activity
of NCX. Firstly, the caﬀeine evoked peak inward current is a generally
accepted measure of forward mode activity after maximal SR Ca2+
release (Diaz et al., 1997). In this case the available NCX in the presence
of ORM-10962 is faced with a signiﬁcantly increased [Ca2+]i, since the
elevated SR Ca2+ content (see above) is combined with a reduced rate
of Ca2+ removal. On the other hand, inward tail currents recorded upon
repolarization to the holding potential are also believed to be mediated
by forward NCX activity (Hove-Madsen et al., 2001). If this current is
activated immediately after emptying the SR by a caﬀeine pulse, the
reduction of the inward tail current in response to ORM-10962 occurs
under conditions of a similar driving force, since the Ca2+ inﬂux via ICa
for the ﬁrst few pulses is fairly the same in baseline and after applica-
tion of ORM-10962 (see Fig. 5).
This approach is demonstrated in Fig. 6, where 10 mM caﬀeine was
applied to deplete the SR and giving simultaneously the measure of
peak INCX at high [Ca2+]i, and NCX tail currents recorded upon re-
polarization following 0 mV test pulses were recorded after termination
of caﬀeine superfusion in the same cell. The dramatic elevation of
[Ca2+]i is reﬂected by the signiﬁcantly increased amplitude of CS
(Fig. 6B) and [Ca2+]i, transient (Fig. 6C).
When the relative forward mode NCX blockade was estimated from
these data, it turned out that the apparent NCX block induced by 1 µM
ORM-10962 was signiﬁcantly weaker (28.5± 4.5% versus
50.5±4.4%, P<0.05, n = 6), when it was determined from the
caﬀeine-induced inward current under conditions of highly elevated
[Ca2+]i comparing to the suppression obtained from inward current
tails (Fig. 6A). During this protocol the corresponding average [Ca2+]i
values were 659± 40 and 257± 32 nM (n = 5), suggesting an inverse
linear relationship between the apparent inhibition and the actual
[Ca2+]i. Since under high [Ca2+]i conditions the measured inward NCX
current might be contaminated with Ca2+-induced Cl- current, some of
these experiments were repeated in the presence of 200 µM DIDS, with
no diﬀerent pattern of the apparent NCX inhibition (not shown).
4. Discussion
In the present study the positive inotropic eﬀect of NCX inhibition
was evaluated using a new, highly selective NCX inhibitor ORM-10962.
We have demonstrated the followings: (1) ORM-10962 has no direct
blocking eﬀect on L-type Ca2+ channels in the absence of SR Ca2+
release, but strongly suppresses ICa under conditions of normal Ca2+
cycling. (2) The inotropic action of NCX inhibition strictly depends on
the experimental conditions: inhibition of the previously activated re-
verse mode results in negative, while forward mode blockade in posi-
tive inotropy. (3) The NCX inhibitory action of ORM-10962 is func-
tionally asymmetrical: the shift in Ca2+ handling appears to be more
pronounced in the reverse than in the forward mode NCX blockade,
likely because Ca2+ accumulation caused by forward mode NCX in-
hibition is eﬀectively attenuated by the autoregulation of Ca2+ handling
and also by the sustained inducibility of NCX by the elevated [Ca2+]i,
which provides an increased driving force for forward mode operation.
4.1. Eﬀects of ORM-10962 on ICa
Our argumentation used for interpretation of the present results
critically depends on the statement that ORM-10962 exerts no direct
suppressive eﬀect on L-type Ca2+ channels. This conclusion is based on
the following ﬁndings. (1) Amplitudes of ICa traces were identical in the
absence and presence of ORM-10962 when changes in [Ca2+]i were
prevented by 10 mM internal BAPTA. (2) ORM-10962 had no eﬀect on
ICa when the Ca2+ content of the SR was depleted by caﬀeine. (3) The
inhibitory eﬀect of ORM-10962 on ICa gradually returned as SR became
reﬁlled allowing for gradually increasing Ca2+ release. On the other
hand, ICa was markedly suppressed by ORM-10962 under conditions of
normal Ca2+ cycling. This is important for two reasons. Firstly, because
this secondary reduction in Ca2+ inﬂux may be involved in compen-
sation for consequences of forward mode NCX blockade, and may
therefore limit the expected positive inotropy. Secondly, because the
reduction in ICa is a strong evidence of elevation of [Ca2+]i in the
submembrane compartment, which can be considered as a signal for
turning on a compensatory alternative Ca2+ eliminating mechanism
(Henderson et al., 2004).
4.2. Marginal positive inotropy under baseline conditions
The concentration of 1 µM ORM-10962 applied in this study was
chosen to cause approximately 80% inhibition of NCX (Kohajda et al.,
2016). Since the relative contribution of the reverse mode NCX activity
is believed to be moderate under baseline conditions, consequences of
forward mode inhibition should be more pronounced. An approxi-
mately 80% reduction in Ca2+ eﬄux due to forward mode NCX
blockade should produce a signiﬁcant Ca2+ accumulation in the SR
with a subsequent increase in Ca2+ release and positive inotropy
(Fig. 1). Surprisingly, application of ORM-10962 under normal condi-
tions caused only a moderate positive inotropic action. The underlying
mechanisms can be divided into two main categories: (1) possible
asymmetrical NCX blockade by ORM-10962 with dominantly reverse
mode inhibition and (2) asymmetrical consequences of the reverse and
forward mode inhibition in Ca2+ handling.
4.3. Inotropic eﬀect of NCX inhibition depends on the relative contribution
of reverse NCX activity
In our previous study, we described clear negative inotropic action
of NCX blockade when the reverse mode was facilitated by low NaCl-
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containing Tyrode solution (Kohajda et al., 2016). In line with this, here
we report that application of ORM-10962 reduced the Ca2+ content of
the SR following a previous enhancement of reverse mode NCX activity
(Fig. 2A and C). These observations were similar to those of our earlier
work using another NCX inhibitor ORM-10103. In that study ORM-
10103 completely reversed or prevented the elevation of [Ca2+]i when
reverse mode NCX was facilitated by veratrine or ATX-II (Nagy et al.,
2014). In contrast, our previous (Kohajda et al., 2016) and the present
study showed that the positive inotropic eﬀect of the selective forward
mode NCX inhibition (when reverse direction of NCX was not allowed
to work) was much weaker than could be expected from the approx.
80% inhibition of NCX obtained in Ca2+ buﬀered myocytes (Varro
et al., 1993).
4.4. Possibility of an asymmetrical NCX blockade
Although theoretical considerations do not support the possibility of
a mode selective NCX inhibition (Noble and Blaustein, 2007), there is
evidence showing that apparent transport mode-dependent inhibition
may occur under certain experimental conditions (Lee and Hryshko,
2004). KB-R7943, as well as SEA0400 are generally considered to block
preferentially the reverse mode NCX (Birinyi et al., 2005; Elias et al.,
2001). Using the same experimental protocol in Ca2+-buﬀered myo-
cytes, however, we were unable to show any preferential inhibition by
ORM-10962 or ORM-10103 (Jost et al., 2013; Kohajda et al., 2016),
and we assume that the possibility of asymmetrical inhibition of the two
opposite NCX operations as a basis for the limited positive inotropic
eﬀects can be ruled out in our experiments.
Another potential mechanism that may alleviate the forward NCX
blockade, and thus the positive inotropic eﬀect, is the possible mod-
ulatory eﬀect of Ca2+ on the NCX inhibition. Such a phenomenon has
been implicated in the case of KB-R7943 (Watano and Kimura, 1998).
In a previous study we also found some evidence supporting such an
eﬀect when SEA0400 was applied to block NCX (Birinyi et al., 2008).
4.5. Asymmetrical consequences of NCX inhibition in Ca2+ handling
Under conditions favouring the forward mode NCX activity, the
observed moderate positive inotropy emphasizes the potential im-
portance of adaptive changes in the balance of Ca2+ inﬂux and eﬄux.
These mechanisms may include: (1) Adaptive changes in Ca2+ inﬂux
via ICa due to elevation of submembrane [Ca2+]i. (2) Activation of an
alternative Ca2+ removal mechanism (e.g. the sarcolemmal Ca2+ ATP-
ase) by the elevated submembrane [Ca2+]i. In this case, however, the
contribution of reverse mode NCX activity to normal Ca2+ handling is
strongly underestimated - or the signiﬁcance of the forward mode NCX
activity in Ca2+ removal is overestimated. (3) Preserved inducibility of
forward NCX activity by high [Ca2+]i following NCX blockade.
4.5.1. Adaptive changes in Ca2+ inﬂux following NCX inhibition
The function of autoregulation is to limit the eﬀects of perturbations
in Ca2+ handling and maintain normal Ca2+ cycling and contractility
(Eisner et al., 2000). Since SERCA and NCX are competing for Ca2+
during relaxation, signiﬁcant increase in Ca2+ sequestration into the SR
Fig. 6. Apparent inhibition of the inward NCX-current by 1 µM ORM-10962 is attenuated by higher [Ca2+]i levels. A: Representative traces of inward NCX-currents evoked by total SR
Ca2+ release in response to 10 mM caﬀeine (left) and INCX tail currents recorded without SR Ca2+ release in response to voltage pulses applied after caﬀeine (right) in the absence (ﬁlled
symbols) and presence (open symbols) of 1 µM ORM-10962. Panel B shows the corresponding representative CS curves (left) and the individual and average eﬀects of ORM-10962 on CS
obtained in 9 myocytes (right). Panel C displays a separate experiment where the eﬀect of ORM-10962 is shown on [Ca2+]i transient recorded using the protocol above. D: Apparent
degree of NCX inhibition as estimated by the reduction of peak NCX currents (left) and tail currents (right) compared in 6 myocytes. Dashed lines indicate corresponding data. Open and
closed symbols represent results obtained in the presence and absence of ORM-10962, respectively. Symbols and bars are mean± S.E.M. values, asterisks denote signiﬁcant diﬀerences
between control and OMR-10962-treated values.
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can be expected after forward mode NCX blockade as causing stronger
Ca2+ release. Since inactivation of L-type Ca2+ channels is under tight
control of local Ca2+ (Acsai et al., 2011; Sipido et al., 1995) the in-
creased SR Ca2+ release may limit the Ca2+ inﬂux through Ca2+
channels, facilitating the development of a new steady state reached at
lower rates of Ca2+ eﬄux and inﬂux. Indeed, in our experiments the
increased SR Ca2+ content in response to the ORM-10962 was paral-
leled by a considerable decrease in Ca2+ inﬂux, deduced from the di-
minished amplitude of ICa. The concept of autoregulation can also help
to interpret the slight positive inotropy under baseline conditions. Al-
though in these Ca2+ transient measurements we could measure nei-
ther Ca2+ inﬂux nor the Ca2+ content of the SR, we can speculate that
the capacity of the autoregulatory mechanisms may be high enough to
largely compensate for the reduced Ca2+ eﬄux (Pott et al., 2005)
causing only a marginal shift in the Ca2+ balance. However, when Ca2+
cycling is activated by forskolin (Fig. 2B and D), the elevated local
Ca2+ might compromise the original capacity of autoregulation, thus
the reduced Ca2+ eﬄux after NCX inhibition cannot be balanced, which
results in a net Ca2+ accumulation with positive inotropic con-
sequences. Nevertheless, this issue requires further investigation.
4.5.2. Possible contribution of alternative Ca2+ removal pathways
The marginal positive inotropic action of NCX inhibition under
baseline conditions may also be explained by involvement of alter-
native Ca2+ removal mechanisms, e.g. the sarcolemmal Ca2+-ATP-ase,
however it has relatively small Ca2+ removal capacity under physio-
logical conditions (Choi and Eisner, 1999). Its enhancement by the
elevated submembrane [Ca2+]i may compensate for the decay in for-
ward mode NCX activity, explaining the lack of Ca2+ overload and cell
death following NCX blockade in healthy canine cardiac cells.
4.5.3. Preserved inducibility of forward mode NCX by elevated [Ca2+]i
The degree of forward mode NCX inhibition can be inferred from
inward NCX current traces recorded in the absence and presence of an
NCX inhibitor. In the presence of caﬀeine, the total SR Ca2+ is released,
which is subsequently removed from the cytoplasm by forward mode
NCX activity. The generated inward current is used to estimate the SR
Ca2+ content and the magnitude of forward NCX. From our experi-
ments it is obvious that ORM-10962 is unable to block forward mode
NCX completely (Fig. 6A), and the degree of inhibition calculated from
peak NCX current traces reached only approx. 30% - much less than the
80% blockade expected from the experiments in Ca2+ buﬀered cells
using similar drug concentrations (Jost et al., 2013; Kohajda et al.,
2016). Since the degree of caﬀeine-induced contracture, and conse-
quently the peak [Ca2+]i values, were signiﬁcantly elevated in the
presence of ORM-10962, it is obvious that the remaining NCX operates
under conditions of a highly elevated driving force. The degree of the
apparent inhibition may therefore be attenuated by the increased
driving force for Ca2+ removal, implicating that the inhibition of NCX
by ORM-10962 is a dynamic phenomenon. The hypothesis of dynamic
NCX blockade is supported by inhibition of NCX tail currents recorded
immediately after depletion of SR Ca2+ content by caﬀeine. Since no
Ca2+ release occurs during the initial post-caﬀeine stimulation pulses,
the elevation of [Ca2+]i may be solely due to Ca2+ inﬂux mediated by
ICa, which is practically the same for the ﬁrst few ICa traces even in the
presence of ORM-10962, resulting in no substantial increase in NCX
driving force. In this case the ORM-10962 displayed approx. 50% in-
hibition of the NCX tail current, indicating a more pronounced NCX
blockade compared to the 30% inhibition obtained at high [Ca2+]i le-
vels evoked by the caﬀeine exposure. Thus, the partial escape of NCX
from the inhibition may cause an asymmetrical inhibition of the NCX,
with less pronounced consequences of forward mode inhibition. In this
sense the inhibition provided by ORM-10962 may be manifested as a
reduced sensitivity to the activator Ca2+, meaning that inward NCX
current with baseline amplitude can be activated even in the presence
of ORM-10962, but it requires a considerably higher level of [Ca2+]i.
4.6. Therapeutic implications: NCX inhibition as a possible positive
inotropic intervention
Our results suggest that ORM-10962 appears to inhibit NCX asym-
metrically in intact myocytes, exerting a dominant eﬀect on reverse
mode NCX activity. As a consequence, when Ca2+ inﬂux via reverse
mode NCX signiﬁcantly contributes to Ca2+ balance, its inhibition will
be pronounced, resulting in a decreased cellular Ca2+ content and a net
negative inotropic eﬀect. The positive inotropy due to forward mode
NCX inhibition may become apparent only when reverse mode NCX is
suppressed and Ca2+ cycling is stimulated independently from the
Ca2+ inﬂux through reverse mode NCX. Increased reverse NCX activity
is a characteristic feature of heart failure, and the NCX inhibition by
ORM-10962 will deﬁnitely block reverse mode NCX as well, which is a
rescue mechanism to maintain the cellular Ca2+ load. This is not ne-
cessarily balanced by the decreased Ca2+ loss, since this latter appears
to be a less pronounced consequence of NCX inhibition. Furthermore it
is important to note that the expression levels of the channel proteins
are markedly modiﬁed in heart failure which may further inﬂuence the
eﬀect of selective NCX inhibition on Ca2+ handling. Thus, the possi-
bility of improving cardiac inotropy by pharmacological NCX inhibition
requires further detailed studies performed in cardiac cells deriving
from failing hearts.
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